NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Human Papillomavirus



Reports outline human papillomavirus study results from A. Satyaprakash et al



May 13th, 2009

According to recent research from the United States, "Cervical and other cancers linked to the human papillomavirus (HPV) are a cause of significant morbidity and mortality."

"Since the discovery of HPV as a cause of these cancers, there has been much research and development in the field of HPV vaccination. Two current prophylactic vaccines have proved highly effective in preventing disease because of the vaccine types," wrote A. Satyaprakash and colleagues.

The researchers concluded: "Recent advances in prophylactic and therapeutic vaccines are discussed."

Satyaprakash and colleagues published their study in Dermatologic...


Source: Vaccine Weekly (2009-05-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login